-+ 0.00%
-+ 0.00%
-+ 0.00%

*Enanta Pharma On Track to File IND for EPS-3903, an Oral, Once-Daily STAT6 Inhibitor and to Select MRGPRX2 Development Candidate, in 2H >ENTA

Dow Jones·08/10/2026 20:11:00

Please log in to view news